Malignant Bowel Obstruction in Patients With Recurrent Ovarian Cancer

Elizabeth Tran; Clayton Spiceland; Nicole P. Sandhu; Aminah Jatoi

doi:10.1177/1049909114566225

Malignant Bowel Obstruction in Patients With Recurrent Ovarian Cancer

Elizabeth Tran, Clayton Spiceland, Nicole P. Sandhu, Aminah Jatoi

Research output: Contribution to journal › Article › peer-review

13 Scopus citations

Abstract

We sought to report incidence, risk factors, and survival related to bowel obstruction in 311 ovarian cancer patients with recurrent disease. A total of 68 (22%) had a documented bowel obstruction during their cancer course, and 49 (16%) developed it after cancer recurrence. Surprisingly, 142 (45%) fit into an “unknown” category (3+ months of data lacking from last contact/death). No risk factors were identified; management included surgery (n = 21), conservative measures (n = 21), and other (n = 7). Documented bowel obstruction was not associated with a statistically significant reduction in survival after cancer recurrence. In conclusion, although bowel obstruction occurs in only a subgroup of patients with ovarian cancer and does not appear to detract from survival after cancer recurrence, limited end-of-life information may be resulting in an underestimation of incidence.

Original language	English (US)
Pages (from-to)	272-275
Number of pages	4
Journal	American Journal of Hospice and Palliative Medicine
Volume	33
Issue number	3
DOIs	https://doi.org/10.1177/1049909114566225
State	Published - Apr 1 2016

Keywords

bowel obstruction
end of life
morbidity
ovarian cancer

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1177/1049909114566225

Cite this

@article{7c259f3fd25d4ed68e232cd65230219b,

title = "Malignant Bowel Obstruction in Patients With Recurrent Ovarian Cancer",

abstract = "We sought to report incidence, risk factors, and survival related to bowel obstruction in 311 ovarian cancer patients with recurrent disease. A total of 68 (22%) had a documented bowel obstruction during their cancer course, and 49 (16%) developed it after cancer recurrence. Surprisingly, 142 (45%) fit into an “unknown” category (3+ months of data lacking from last contact/death). No risk factors were identified; management included surgery (n = 21), conservative measures (n = 21), and other (n = 7). Documented bowel obstruction was not associated with a statistically significant reduction in survival after cancer recurrence. In conclusion, although bowel obstruction occurs in only a subgroup of patients with ovarian cancer and does not appear to detract from survival after cancer recurrence, limited end-of-life information may be resulting in an underestimation of incidence.",

keywords = "bowel obstruction, end of life, morbidity, ovarian cancer",

author = "Elizabeth Tran and Clayton Spiceland and Sandhu, {Nicole P.} and Aminah Jatoi",

note = "Publisher Copyright: {\textcopyright} 2014, {\textcopyright} The Author(s) 2014.",

year = "2016",

month = apr,

day = "1",

doi = "10.1177/1049909114566225",

language = "English (US)",

volume = "33",

pages = "272--275",

journal = "American Journal of Hospice and Palliative Medicine",

issn = "1049-9091",

publisher = "SAGE Publications Inc.",

number = "3",

}

TY - JOUR

T1 - Malignant Bowel Obstruction in Patients With Recurrent Ovarian Cancer

AU - Tran, Elizabeth

AU - Spiceland, Clayton

AU - Sandhu, Nicole P.

AU - Jatoi, Aminah

PY - 2016/4/1

Y1 - 2016/4/1

N2 - We sought to report incidence, risk factors, and survival related to bowel obstruction in 311 ovarian cancer patients with recurrent disease. A total of 68 (22%) had a documented bowel obstruction during their cancer course, and 49 (16%) developed it after cancer recurrence. Surprisingly, 142 (45%) fit into an “unknown” category (3+ months of data lacking from last contact/death). No risk factors were identified; management included surgery (n = 21), conservative measures (n = 21), and other (n = 7). Documented bowel obstruction was not associated with a statistically significant reduction in survival after cancer recurrence. In conclusion, although bowel obstruction occurs in only a subgroup of patients with ovarian cancer and does not appear to detract from survival after cancer recurrence, limited end-of-life information may be resulting in an underestimation of incidence.

AB - We sought to report incidence, risk factors, and survival related to bowel obstruction in 311 ovarian cancer patients with recurrent disease. A total of 68 (22%) had a documented bowel obstruction during their cancer course, and 49 (16%) developed it after cancer recurrence. Surprisingly, 142 (45%) fit into an “unknown” category (3+ months of data lacking from last contact/death). No risk factors were identified; management included surgery (n = 21), conservative measures (n = 21), and other (n = 7). Documented bowel obstruction was not associated with a statistically significant reduction in survival after cancer recurrence. In conclusion, although bowel obstruction occurs in only a subgroup of patients with ovarian cancer and does not appear to detract from survival after cancer recurrence, limited end-of-life information may be resulting in an underestimation of incidence.

KW - bowel obstruction

KW - end of life

KW - morbidity

KW - ovarian cancer

UR - http://www.scopus.com/inward/record.url?scp=84959019523&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959019523&partnerID=8YFLogxK

U2 - 10.1177/1049909114566225

DO - 10.1177/1049909114566225

M3 - Article

C2 - 25552305

AN - SCOPUS:84959019523

SN - 1049-9091

VL - 33

SP - 272

EP - 275

JO - American Journal of Hospice and Palliative Medicine

JF - American Journal of Hospice and Palliative Medicine

IS - 3

ER -

Malignant Bowel Obstruction in Patients With Recurrent Ovarian Cancer

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this